Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|September 9, 2020
Fructosamine-3-Kinase as a Potential Treatment Option for Age-Related Macular DegenerationSander De Bruyne, Caroline Van den Broecke, Henk Vrielinck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2002
Primary peripheral PNET/Ewing's sarcoma of the dura: a clinicopathologic entity distinct from central PNETFranceska Dedeurwaerdere, Caterina Giannini, Raf Sciot, et al.
JAMA Network Open|December 11, 2025
Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer PopulationLucas F van Schaik, Brigitte Maes, Pieter-Jan Volders, et al.
Cancers|February 25, 2022
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing ApproachBénedith Oben, Charlotte Cosemans, Ellen Geerdens, et al.
Plos One|January 14, 2014
Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1Leila Rouhigharabaei, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2025
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)Kristof Cuppens, Marcel Wiesweg, Paul Baas, et al.
Clinical Chemistry|July 20, 2025
Diagnostic Value of Digital Estimates of Trophoblastic Mosaicism in Genome-Wide Cell-Free Fetal DNA ScreeningGeert A Martens, Dieter De Smet, Guy Froyen, et al.
Nature Medicine|April 30, 2024
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trialMartin Schuler, Kristof Cuppens, Till Plönes, et al.
Molecular Oncology|January 31, 2025
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnosticsGuy Froyen, Pieter-Jan Volders, Ellen Geerdens, et al.
Frontiers in Digital Health|April 23, 2026
Advancing the adoption of oncology decision support tools in Europe: insights from CAN.HEALNancy Frederickx, Guy Froyen, Maud Kamal, et al.
Pageof 8